Risankizumab, guselkumab, and ustekinumab were associated with the lowest risk for progression from psoriasis to psoriatic arthritis.

Public Service Co. of Oklahoma has applied to the state Corporation Commission for an “adjustment” in its rates that would ...

Content by Public Service Company of Oklahoma. Learn how the Public Service Company of Oklahoma keeps the lights on for customers through every possible weather outcome.

Mar 28, 2026-- Takeda ( TSE:4502/NYSE:TAK ) today announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279 ...

A Pasco County pastor and former deputy was arrested on multiple charges of lewd and lascivious behavior and molestation involving minors, according to the sheriff's office.

A New Port Richey pastor and former deputy was charged by the Pasco Sheriff's Office with lewd and lascivious behavior ...

The European Medicines Agency has endorsed expanded use of Sotyktu for psoriatic arthritis, recommending approval after clinical trials showed improvement in joint symptoms.

Alumis is preparing to file its oral TYK2 inhibitor envudeucitinib as a treatment for psoriasis later this year, after a pair of positive phase 3 trials. The South San Francisco biotech said ...

Pearson plc is leveraging AI-driven efficiency and digital transformation to drive sustained margin expansion and free cash flow growth. Learn more about PSO stock here.

When a Tulsa man couldn't get PSO to clean up a mess left by its powerline tree trimmers, 2 News Oklahoma's Cathy Tatom listened and got results.

Adding tirzepatide to ixekizumab significantly improved primary and key secondary outcomes ...